Galectin Therapeutics Corporate Presentation 2016

Galectin Therapeutics is a drug development company focused on developing treatments for diseases where galectin-3 proteins are implicated, with a primary focus on addressing the unmet medical need for patients with cirrhosis caused by non-alcoholic steatohepatitis (NASH). The presentation outlines the company's strategy and clinical trial progress in this therapeutic area.